This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.
Phase 1 data presented by Andrew Brenner, MD, PhD, showed RNL-186 improved survival, reduced symptoms, and demonstrated ...
The ustekinumab (Stelara; Janssen Biotech) biosimilar DMB-3115 (Imuldosa; Accord BioPharma) demonstrated clinical efficacy and safety comparable to the reference product through 52 weeks in a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback